Guggenheim Securities analyst Jonathan Lee downgraded Accenture (ACN) from Buy to Neutral, citing a lack of improvement in demand despite a significant stock rebound. The downgrade is based on channel checks indicating extended decision cycles, competitive pricing pressure, and a lack of recovery in discretionary spending, leading to expectations of below-1% organic growth for Q4.
Guggenheim analyst Jonathan Lee downgraded Accenture (ACN) from Buy to Neutral, expressing concerns about demand despite the stock's recent 52% rebound. This downgrade is significant as it suggests that the market's optimism for ACN may be unfounded given the underlying business conditions. The analyst's channel checks indicate persistent challenges like extended decision cycles, competitive pricing, and a lack of discretionary spending recovery, which are expected to result in below-1% organic growth for Q4. This could lead to short-term downward pressure on ACN shares as investors digest the revised outlook and potential for a modest 2-5% revenue growth projection for fiscal 2027, which is seen as limiting upside given the current valuation.